[{"status": "Ongoing", "city": "Newmarket", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95655", "recalling_firm": "Brands International Corporation", "address_1": "594 Newpark Blvd", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0205-2025", "product_description": "Kissable Diabetics Foot Cream, NET WT 4 oz (113 g) per tube, Manufactured By: Brands International Corp., Newmarket, ON, L3X 2S2. UPC 6 72008 80925 3", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviations: lack of adequate release testing.", "recall_initiation_date": "20241113", "center_classification_date": "20250117", "report_date": "20250129", "code_info": "Lots: 23319025, 23318024, 23313023, 23311022, 23310021, 23222021, 23220020, 23215019, 23215018, 23214017, 23213016, 23208015, 2313014, 2312213, 2312212, 2312111, 2312110, 2311709, 2311708, 2311607, 2311506, 2311405, 2307904, 23073003, 23072002, 2306901 and 24135003.  All expiration dates within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0236-2025", "product_description": "Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30.", "product_quantity": "87,600 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234153, Exp.: 9/2025; 19234900, 19234929, Exp.: 11/2025; 19240936, 19240942, Exp.: 2/2026; 19243199, 19243190, Exp.:7/2026; 19244013, 19244014, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96033", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0202-2025", "product_description": "glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11", "product_quantity": "2,028 units (cartons of 30 individual unit doses)", "reason_for_recall": "Failed Dissolution Specifications:", "recall_initiation_date": "20241217", "center_classification_date": "20250116", "report_date": "20250122", "code_info": "Lot # 1012910, Exp Date: 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96391", "recalling_firm": "Chattem Inc", "address_1": "1715 W 38th St", "address_2": "", "postal_code": "37409-1248", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0266-2025", "product_description": "Unisom, SleepMelts, Diphenhydramine HCl tablets, 25 mg, Nighttime Sleep-Aid, 4 x 8 blister packs per carton, Cherry flavor, Manufactured by Adare Pharmaceuticals, Inc., Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409, UPC # 0 41167 0014 0", "product_quantity": "180,696 cartons", "reason_for_recall": "CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.", "recall_initiation_date": "20250304", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot#  252807, Exp: 5/31/2025; 252808, Exp: 6/30/2025; 372560, Exp: 11/30/2025; 489576, 493447, Exp: 4/30/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96191", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0217-2025", "product_description": "Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.", "product_quantity": "247 blister packs", "reason_for_recall": "CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.", "recall_initiation_date": "20250124", "center_classification_date": "20250203", "termination_date": "20250717", "report_date": "20250212", "code_info": "Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0195-2025", "product_description": "Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.", "product_quantity": "14825 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-306-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0179-2025", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-306-02 (carton), NDC #: 49884-306-52 (blisters).", "product_quantity": "8,029 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot #: 550174101, Exp. 01/31/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M012"], "brand_name": ["GUAIFENESIN AND CODEINE PHOSPHATE"], "generic_name": ["GUAIFENESIN AND CODEINE PHOSPHATE"], "manufacturer_name": ["PAI Holdings, LLC"], "product_ndc": ["0121-0775", "0121-1775", "0121-1550"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CODEINE PHOSPHATE", "GUAIFENESIN"], "rxcui": ["995868"], "spl_id": ["2175415b-f07e-50a6-e063-6394a90acabe"], "spl_set_id": ["88d0994c-4270-4408-8837-bd97510b2118"], "package_ndc": ["0121-0775-04", "0121-0775-08", "0121-0775-16", "0121-1775-05", "0121-1775-00", "0121-1775-10", "0121-1775-40", "0121-1550-10", "0121-1550-00", "0121-1550-40"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["495W7451VQ", "GSL05Y1MN6"]}, "product_type": "Drugs", "event_id": "96119", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0222-2025", "product_description": "Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16", "product_quantity": "4080 Bottles", "reason_for_recall": "Superpotent; sodium benzoate preservative", "recall_initiation_date": "20250107", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot number 4B07, Exp Date: 2026-OCT-31", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95853", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0161-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "163,883 bottles", "reason_for_recall": "CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot #  222205C, exp. date 11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212144"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-861", "68462-862", "68462-863", "68462-864", "68462-865"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["440a4208-83cc-4ffa-952c-d9c0745c342a"], "spl_set_id": ["a6065ac5-a111-449b-b51b-8bc2907d1ddb"], "package_ndc": ["68462-861-01", "68462-861-10", "68462-862-01", "68462-862-10", "68462-863-01", "68462-863-10", "68462-864-01", "68462-864-10", "68462-865-01", "68462-865-10"], "is_original_packager": [true], "upc": ["0368462862018", "0368462864012", "0368462863015", "0368462861011"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "95936", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0159-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01", "product_quantity": "3,888", "reason_for_recall": "CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20241211", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Grand Prairie", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96465", "recalling_firm": "Fruit Of The Earth, Inc.", "address_1": "1430 Avenue R", "address_2": "N/A", "postal_code": "75050-1605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0284-2025", "product_description": "CVS Health Concealing Acne Treatment Cream, CVS, 10% benzoyl peroxide, 1 oz (28 g), Distributed by: CVS Pharmacy, Inc", "product_quantity": "112045 tubes", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20250311", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 4970743A, Exp 3/31/2026; 9712793A,  Exp9/30/2026; 8363513B, Exp 12/31/2026; 1391304A, 5101574A, Exp 5/31/2027; 1292084A, 1292084B, 1292084C, Exp 7/31/2027; 2892384A, Exp 8/31/2027; 6203044A, 6203044B, Exp 10/31/2027; 2153564A, 2153564B, Exp 12/31/2027; 2163564A, Exp 1/31/2028"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209718"], "brand_name": ["CLOBAZAM"], "generic_name": ["CLOBAZAM"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOBAZAM"], "rxcui": ["199450"], "spl_id": ["3d5d1f23-c639-3604-e063-6294a90ac606"], "spl_set_id": ["8fce3252-95f8-4428-9922-5ba308e20177"], "package_ndc": ["60687-423-11", "60687-423-21"], "original_packager_product_ndc": ["69238-1305"], "nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "unii": ["2MRO291B4U"]}, "product_type": "Drugs", "event_id": "96117", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0201-2025", "product_description": "Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-11", "product_quantity": "4640 units", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20250107", "center_classification_date": "20250114", "report_date": "20250122", "code_info": "Lot #: 1018598, Exp. Date 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0198-2025", "product_description": "Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.", "product_quantity": "456 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDC0124002B Exp 09/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "96014", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0182-2025", "product_description": "Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05", "product_quantity": "136,181 bottles", "reason_for_recall": "Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20241216", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Thousand Oaks", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103353"], "brand_name": ["NEUPOGEN"], "generic_name": ["FILGRASTIM"], "manufacturer_name": ["Amgen, Inc"], "product_ndc": ["55513-209", "55513-530", "55513-546", "55513-924"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["FILGRASTIM"], "rxcui": ["727535", "727537", "727544", "727545", "1649944", "1649946", "1649963", "1649964"], "spl_id": ["cc41b9c3-f2de-416f-9396-acdc8dac69b9"], "spl_set_id": ["97cc73cc-b5b7-458a-a933-77b00523e193"], "package_ndc": ["55513-530-01", "55513-530-10", "55513-530-20", "55513-546-01", "55513-546-10", "55513-546-20", "55513-924-01", "55513-924-10", "55513-924-91", "55513-924-20", "55513-209-01", "55513-209-10", "55513-209-91", "55513-209-20"], "is_original_packager": [true], "upc": ["0355513530101", "0355513546102"], "nui": ["M0024696", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["PVI5M0M1GW"]}, "product_type": "Drugs", "event_id": "96325", "recalling_firm": "Amgen, Inc.", "address_1": "1 Amgen Center Dr", "address_2": "N/A", "postal_code": "91320-1730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy/San Marino, Netherlands, Poland, Spain/Andorra, Sweden, Finland, Switzerland/Liechtenstein, United Kingdom of Great Britain and Northern Ireland, Ireland, Denmark, Canada, Hong Kong, Philippines, Israel, Malaysia, Saudi Arabia, Gibraltar.", "recall_number": "D-0285-2025", "product_description": "Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-530-01 (vial), NDC 55513-530-10 (box).", "product_quantity": "313,620 Vials", "reason_for_recall": "Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.", "recall_initiation_date": "20250227", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 1147300, 1147300A, Exp.: 2/28/2025; 1152064, Exp.:3/31/2025; 1154734, 1156806, Exp.: 8/31/2025; 1159109, Exp.: 10/31/2025; 1163909, Exp.: 2/28/2026; 1164631, Exp.: 5/31/2026; 1171366, 1182097, Exp.:8/31/2026; 1176114, Exp.: 2/28/2027; 1182094, Exp.:7/31/2027."}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205927"], "brand_name": ["PRASUGREL"], "generic_name": ["PRASUGREL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5185", "0378-5186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRASUGREL HYDROCHLORIDE"], "rxcui": ["855812", "855818"], "spl_id": ["9e234352-49b7-46e3-bc59-acf63e0a7a14"], "spl_set_id": ["41a4e332-6725-4cb7-940a-8291cf56cfe4"], "package_ndc": ["0378-5185-93", "0378-5186-93"], "is_original_packager": [true], "upc": ["0303785185932"], "unii": ["G89JQ59I13"]}, "product_type": "Drugs", "event_id": "96369", "recalling_firm": "MYLAN PHARMACEUTICALS INC", "address_1": "1311 Pineview Dr", "address_2": "N/A", "postal_code": "26505-3276", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0280-2025", "product_description": "Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93", "product_quantity": "N/A", "reason_for_recall": "Failed Dissolution Specifications - low dissolution results", "recall_initiation_date": "20250225", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot # 3211073, 3211074, 3211075, Exp 4/30/2026"}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0199-2025", "product_description": "Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02.", "product_quantity": "324 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDC0224001B Exp 09/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210757"], "brand_name": ["COLCHICINE"], "generic_name": ["COLCHICINE"], "manufacturer_name": ["Granules Pharmaceutical Inc."], "product_ndc": ["70010-001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLCHICINE"], "rxcui": ["1550940"], "spl_id": ["3836b9fe-5628-fe23-e063-6294a90aa475"], "spl_set_id": ["16d49c45-5b0a-a7fa-e063-6294a90a7320"], "package_ndc": ["70010-001-01", "70010-001-10", "70010-001-03"], "is_original_packager": [true], "upc": ["0370010001039"], "nui": ["N0000193949", "M0000713"], "pharm_class_epc": ["Alkaloid [EPC]"], "pharm_class_cs": ["Alkaloids [CS]"], "unii": ["SML2Y3J35T"]}, "product_type": "Drugs", "event_id": "96026", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0187-2025", "product_description": "Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03", "product_quantity": "96 Bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.", "recall_initiation_date": "20241218", "center_classification_date": "20250107", "termination_date": "20250701", "report_date": "20250115", "code_info": "Lot#: GPC240763B, Exp. Date 6/17/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "96495", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0282-2025", "product_description": "Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05", "product_quantity": "90960 bottles", "reason_for_recall": "Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20250311", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot: 084A067, Exp 12/31/2025"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078203"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6007", "0904-6008", "0904-6009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LORAZEPAM"], "rxcui": ["197900", "197901", "197902"], "spl_id": ["6b6c2fbc-d12d-41d7-b49d-cf374c773cbd"], "spl_set_id": ["62f6eb3b-813d-4890-aca9-799b7fa890df"], "package_ndc": ["0904-6007-60", "0904-6007-61", "0904-6008-60", "0904-6008-61", "0904-6009-60", "0904-6009-61"], "original_packager_product_ndc": ["69315-904", "69315-905", "69315-906"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "96151", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide U.S. and Puerto rico", "recall_number": "D-0226-2025", "product_description": "Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61", "product_quantity": "82,281 cartons", "reason_for_recall": "Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.", "recall_initiation_date": "20250121", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96162", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0216-2025", "product_description": "Carvedilol Tablets, USP, 12.5 mg, Rx only, a)500 Tablets, NDC 68462-164-05; b) 100 Tablets, NDC 68462-164-01, Manufactured for Glenmark Pharmaceuticals, NJ.", "product_quantity": "", "reason_for_recall": "CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20250122", "center_classification_date": "20250203", "report_date": "20250212", "code_info": "Lot numbers: a) 17230658, Exp.: 02/2025; 17230814,17230822, Exp.: 03/2025; 17231004,17231009,17231022, Exp.: 04/2025; 17231393,17231392, Exp.: 05/2025; 17231538, 17231541,17231542, Exp.: 06/2025; 17231710,17231718,17231721,17231722,17231730, Exp': 07/2025; 17232169, Exp.: 09/2025; 17232253, Exp.: 10/2025; 17240220,17240240, Exp.: 01/2026; 17240459, Exp.: 02/2026   b) 17230814, Exp.: 03/2025; 17231392, Exp.:05/2025; 17232260, Exp.: 10/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Maryland Heights", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078098"], "brand_name": ["TECHNETIUM TC 99M SESTAMIBI"], "generic_name": ["TECHNETIUM TC 99M SESTAMIBI"], "manufacturer_name": ["Curium US LLC"], "product_ndc": ["69945-092"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE"], "spl_id": ["4b00526c-6250-49d7-ba34-459ef89c8f43"], "spl_set_id": ["4110d0f4-3bcf-4688-a39f-42a81064c796"], "package_ndc": ["69945-092-20", "69945-092-40"], "is_original_packager": [true], "unii": ["N6OU7HJ70P"]}, "product_type": "Drugs", "event_id": "95839", "recalling_firm": "Curium US, LLC", "address_1": "2703 Wagner Pl", "address_2": "", "postal_code": "63043-3421", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Canada.", "recall_number": "D-0164-2025", "product_description": "Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate -  0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg.  The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only,  Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40", "product_quantity": "5,160 vials (172 kits 30 vials/kit)", "reason_for_recall": "Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product", "recall_initiation_date": "20241126", "center_classification_date": "20241226", "termination_date": "20251010", "report_date": "20250101", "code_info": "Lot 092-24006, Catalog # N092D0, Exp 06/15/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0263-2025", "product_description": "Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.", "product_quantity": "5.1 kg", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HACUC0010722, exp. date Jun-2025 HACUC0010123, exp. date Dec-2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0156-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05", "product_quantity": "13,678 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot DT3023030A Exp 2/28/2025", "more_code_info": ""}, {"status": "Completed", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96245", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0246-2025", "product_description": "Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30", "product_quantity": "4944 cartons", "reason_for_recall": "Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.", "recall_initiation_date": "20250206", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot # 193109; Exp. 07/31/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010", "202517231315"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96162", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0215-2025", "product_description": "Carvedilol Tablets, USP, 25 mg, Rx only, a)500 Tablets, NDC 68462-165-05; b) 100 Tablets, NDC 68462-165-01, Manufactured for Glenmark Pharmaceuticals, NJ.", "product_quantity": "", "reason_for_recall": "CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20250122", "center_classification_date": "20250203", "report_date": "20250212", "code_info": "Lot numbers: a) 17230500, 17230509,17230526,17230546,17230551,17230603,17230628, 17230642,17230645,17230681, Exp.:02/2025; 17230829,17230832,17230854, 17230864,17230874,17230876,17230889,17230894, Exp.: 03/2025; 17230960, 17230964,17230976,17230981,17230985,17231161,17231171, Exp.: 04/2025 17231315,17231318,17231332,17231333,17231365, Exp.: 05/2025; 17231539, 17231563, Exp.: 06/2025; 17231653,17231662,17231663,17231680,17231691, 17231781,17231782,17231789, Exp.: 07/2025;17231838,17231880, Exp.: 08/2025; 17232144,17232147,17232151, Exp.: 09/2025; 17232369,17232370,17232408,17232409, 17232416,17232504,17232522,17232531,17232538,17232543, Exp.: 11/2025; 17240377,17240385,17240415,17240422,17240430,17240510, Exp.: 02/2026.  b) 17230551, 17240377, Exp.:02/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0262-2025", "product_description": "Finasteride  NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.", "product_quantity": "120.0 kg", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HAFSC0040923, exp. date Aug-2027 HAFSC0050923, exp. date Aug-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0235-2025", "product_description": "Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-269-30.", "product_quantity": "80,160 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234630, Exp.: 10/2025; 19240528, 19240529, Exp.: 1/2026."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210965"], "brand_name": ["PROGESTERONE"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-306"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PROGESTERONE"], "rxcui": ["312644"], "spl_id": ["44ca9ab1-7336-4914-b059-79559747ac39"], "spl_set_id": ["7d19df3b-94ed-4681-beae-9caaf137d014"], "package_ndc": ["55150-306-10"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "96073", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0186-2025", "product_description": "Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520  NDC # 55150-306-10", "product_quantity": "17,300 10-mL vials", "reason_for_recall": "Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.", "recall_initiation_date": "20241227", "center_classification_date": "20250107", "report_date": "20250115", "code_info": "Batch # 1PR24010, Expiry: 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0239-2025", "product_description": "Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-756-01.", "product_quantity": "119,040 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233228, 19233227, Exp.: 7/2025; 19233757, Exp.: 8/2025; 19234229, Exp.: 9/2025; 19235090, Exp.: 11/2025; 19241471, Exp.:3/2026; 19242180, Exp.: 5/2026."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0244-2025", "product_description": "Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-761-01.", "product_quantity": "58,368 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233270, 19233278, 19233285, Exp.: 7/2025; 19233806, Exp.: 8/2025; 19240954, Exp.: 2/2026; 19241854, Exp.: 4/2026."}, {"status": "Ongoing", "city": "Newton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96052", "recalling_firm": "First Aid Beauty Ltd", "address_1": "70 Bridge St", "address_2": "Suite 203", "postal_code": "02458-1140", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0206-2025", "product_description": "First Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, Net Wt. 396.8 g (14 OZ), DISTR. BY: First Aid Beauty LTD, Newton, MA, 02458, UPC 8 15517 02955 6", "product_quantity": "2756 jars", "reason_for_recall": "CGMP Deviations; product intended for quarantine was inadvertently distributed", "recall_initiation_date": "20241223", "center_classification_date": "20250121", "report_date": "20250129", "code_info": "Lots 24D44, Exp 4/10/2026 & 24D45, 4/11/2026", "more_code_info": ""}, {"status": "Completed", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96306", "recalling_firm": "Turbare Manufacturing", "address_1": "925 Jeanette Dr", "address_2": "N/A", "postal_code": "72032-6651", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0248-2025", "product_description": "Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.", "product_quantity": "1,147 syringes", "reason_for_recall": "Lack of Assurance of Sterility: due to a quality control process deviation. During an internal quality assurance review, an Acceptable Quality Limit (AQL) inspection was not conducted on a statistically sound number of samples. This may result in the inability to assure that the impacted products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess and may lead to products of unacceptable quality.", "recall_initiation_date": "20250218", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025)."}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210921"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7216"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "spl_id": ["9d5dc98f-9e9a-4303-8f20-446e84da3fcf"], "spl_set_id": ["a9d68a40-75e3-4c5c-b5d7-1d6160527fa7"], "package_ndc": ["0904-7216-61"], "original_packager_product_ndc": ["65862-987"], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96201", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0221-2025", "product_description": "Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520.  Made in India.  Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152.  NDC: 0904-7216-61", "product_quantity": "6997 cartons", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20250130", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot# T05224; Exp. 02/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0155-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04", "product_quantity": "21,262 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot DT3023029A Exp 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-068"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM"], "rxcui": ["1188426"], "spl_id": ["435361c6-ed83-3e7b-e063-6394a90ac92f"], "spl_set_id": ["b479d2ae-4b59-916a-e053-2995a90af8ec"], "package_ndc": ["50268-068-15", "50268-068-02"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "96032", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0175-2025", "product_description": "Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by: AvKARE, Pulaski, TN, 38478, NDC 50268-068-15.", "product_quantity": "16,677 cartons", "reason_for_recall": "LABELING: LABEL MIX-UP", "recall_initiation_date": "20241218", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lot #: 0160, Exp. Date April 26 2026", "more_code_info": ""}, {"status": "Completed", "city": "Montgomery", "state": "AL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022363"], "brand_name": ["LIVALO"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["Kowa Pharmaceuticals America, Inc."], "product_ndc": ["66869-104", "66869-204", "66869-404"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861646", "861648", "861650", "861652", "861654"], "spl_id": ["8c680b64-3b3d-486d-b64b-a8645d925bba"], "spl_set_id": ["44dcbf97-99ec-427c-ba50-207e0069d6d2"], "package_ndc": ["66869-104-90", "66869-204-90", "66869-204-07", "66869-404-90", "66869-404-07"], "is_original_packager": [true], "upc": ["0366869404909", "0366869104908"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "96379", "recalling_firm": "Kowa Pharmaceuticals America", "address_1": "530 Industrial Park Blvd", "address_2": "", "postal_code": "36117-5543", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "PA, OH, and TX", "recall_number": "D-0258-2025", "product_description": "Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90  HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case", "product_quantity": "5,328 Bottles", "reason_for_recall": "Presence of foreign tablets/capsules", "recall_initiation_date": "20250224", "center_classification_date": "20250307", "report_date": "20250319", "code_info": "Lot#: 3231300, Exp 8/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Fort Worth", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96003", "recalling_firm": "Alcon Research LLC", "address_1": "6201 South Fwy", "address_2": "", "postal_code": "76134-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0200-2025", "product_description": "Systane Lubricant Eye Drops, Ultra PF, Sterile, 25 Vials (0.7mL Each), Manufactured for: Alcon Laboratories, Inc. Forth Worth, TX 76134", "product_quantity": "55,960 25-count boxes", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20241218", "center_classification_date": "20250113", "report_date": "20250122", "code_info": "Lot 10101; Exp.09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95900", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0165-2025", "product_description": "Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA", "product_quantity": "a) 1,564 cards, b) 799 bottles", "reason_for_recall": "CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241202", "center_classification_date": "20241226", "report_date": "20250101", "code_info": "a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Gilsum", "state": "NH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96122", "recalling_firm": "The W.S. Badger Company, Inc.", "address_1": "768 Route 10", "address_2": "", "postal_code": "03448-7503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0209-2025", "product_description": "BADGER 50, ADVENTURE SPORT MINERAL SUNSCREEN WITH CLEAR ZINC, (uncoated 25% zinc oxide), 2.4 oz., Tin, W.S. Badger Company, Inc, 768 Route 10, Gilsum NH, 03448 UPC 6 34084 47150 2", "product_quantity": "4,834 tins", "reason_for_recall": "Labeling: Missing Label: The finished product potentially  missing the labeling with the drug facts panel, bar code and directions for use.", "recall_initiation_date": "20250117", "center_classification_date": "20250129", "termination_date": "20250707", "report_date": "20250205", "code_info": "LOT# 091923A, Exp. Date 09/19/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96428", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0291-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.", "product_quantity": "1,068 cartons", "reason_for_recall": "Super-Potent Drug: Out of specification potency results were obtained.", "recall_initiation_date": "20250307", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "Lot 3115773, Exp. 03/31/2025"}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95930", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0172-2025", "product_description": "Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03.  packaged in an Airless pump pack", "product_quantity": "2760 packs", "reason_for_recall": "Crystallization", "recall_initiation_date": "20241210", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7043", "0904-7044", "0904-7045"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["d893474d-4a41-4771-88d3-25ea749deeff"], "spl_set_id": ["fdc774b5-c8f2-4daf-94cb-7e73548b541a"], "package_ndc": ["0904-7043-04", "0904-7043-61", "0904-7044-61", "0904-7045-61"], "original_packager_product_ndc": ["57237-017", "57237-018", "57237-019"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96105", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0212-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.", "product_quantity": "a) 6408 boxes and b)1488 boxes", "reason_for_recall": "CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit", "recall_initiation_date": "20250113", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot #: a) N01530, Exp. Date 01/2025; b) N01540, Exp. Date. 01/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0231-2025", "product_description": "Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-265-30.", "product_quantity": "70,032 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232368, Exp:5/2025; 19235088, Exp.: 11/2025; 19241447, Exp.: 3/2026; 19243146, Exp.: 7/2026."}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0250-2025", "product_description": "Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Delivers: 0.05 mL Oral Solution, Mfg by: Westminster, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 69367028302.", "product_quantity": "3069 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #:  24300812, Exp 01/31/2025; 24530836, Exp 07/19/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Northbrook", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050708"], "brand_name": ["PROGRAF"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Astellas Pharma US, Inc."], "product_ndc": ["0469-0607", "0469-0617", "0469-0657", "0469-3016", "0469-1230", "0469-1330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["108513", "108514", "108515", "198377", "198378", "198379", "261134", "313190", "2052605", "2052609", "2052703", "2052704"], "spl_id": ["e9157663-1515-4ba3-83b5-1622cf6f0f99"], "spl_set_id": ["7f667de1-9dfa-4bd6-8ba0-15ee2d78873b"], "package_ndc": ["0469-0607-73", "0469-0617-73", "0469-0617-11", "0469-0657-73", "0469-0657-11", "0469-3016-01", "0469-1230-50", "0469-1330-50"], "is_original_packager": [true], "upc": ["0304690607731", "0304690657736", "0304691230501", "0304691330508", "0304690617730", "0304693016011"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "96008", "recalling_firm": "Astellas Pharma US Inc.", "address_1": "2375 Waterview Dr", "address_2": "", "postal_code": "60062-6145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0211-2025", "product_description": "Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.", "product_quantity": "14,340 100-count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules", "recall_initiation_date": "20241223", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot# 0E3353D, Exp 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96232", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "N/A", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in PA", "recall_number": "D-0225-2025", "product_description": "fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII, Single use  100mL IV Bag, Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67726 Bar Code 71266-5060-01", "product_quantity": "1330 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250131", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot # C274-000040409, Exp 03/22/2025"}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["ZAPZYT ACNE TREATMENT GEL"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Focus Consumer Healthcare, LLC"], "product_ndc": ["71687-0011"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["486131"], "spl_id": ["2df18af1-0ee0-39d1-e063-6394a90ae62a"], "spl_set_id": ["6079d45c-dd86-6f2e-e053-2991aa0a9743"], "package_ndc": ["71687-0011-1"], "is_original_packager": [true], "upc": ["0010768001102"], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "96384", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0273-2025", "product_description": "Zapzyt, Acne Treatment Gel, 10% benzoyl peroxide Gel, packaged in 1 oz (28.35g) tube, Distributed by: FOCUS CONSUMER HEALTHCARE, LLC., 801 Broad St Ste 200, Chattanooga, TN 37402. NDC 71687-0011-1", "product_quantity": "642,131 tubes", "reason_for_recall": "Chemical Contamination: Presence of benzene.", "recall_initiation_date": "20250224", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "Lot #: 9762, Exp. Date 2/28/2025; 9763, 9764, 9765, Exp. Date 3/31/2025; 9869, 9870, Exp. Date 5/31/2025; 9871, 9872, Exp. Date 7/31/2025; 9996, 9997, 9998, Exp. Date 8/31/2025;  9995, Exp. Date 10/31/2025; 0154, 0153, 0326, Exp. Date 1/31/2026; 0155, 0156, 0161,  0327, 0329, 0328, Exp. Date 2/28/2026; 0479, 0480, Exp. Date 5/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210207"], "brand_name": ["CINACALCET HYDROCHLORIDE"], "generic_name": ["CINACALCET HYDROCHLORIDE"], "manufacturer_name": ["Slate Run Pharmaceuticals"], "product_ndc": ["70436-007", "70436-008", "70436-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["bd9ce3c3-15d0-454a-8546-58fa06c3bea7"], "spl_set_id": ["0850ec78-ae46-481e-a6b5-8169cb843eab"], "package_ndc": ["70436-007-04", "70436-008-04", "70436-009-04"], "is_original_packager": [true], "upc": ["0370436009046"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "96433", "recalling_firm": "Slate Run Pharmaceuticals", "address_1": "277 W Nationwide Blvd Ste 260", "address_2": "N/A", "postal_code": "43215-0169", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 8 distributors who may have further distribute the product nationwide.", "recall_number": "D-0279-2025", "product_description": "Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04", "product_quantity": "2,444 bottles", "reason_for_recall": "CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.", "recall_initiation_date": "20250307", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot # 109797, Exp 11/2026"}, {"status": "Ongoing", "city": "Kirkland", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95836", "recalling_firm": "Jubilant Draximage Inc., dba Jubilant Radiopharma", "address_1": "16751 Rte Transcanadienne", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0191-2025", "product_description": "Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection, 10 mL Multi-Dose Reaction Vial, 5 vial Box, Rx Only, Manufactured for: Jubilant Draximage Inc., dba Jubilant Radiopharma, Kirkland , Quebec, H9H, 4J$, Canada, NDC# 65174-179-05.", "product_quantity": "5209 kits", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20241122", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "LOT C2300070 and C2300070E;Exp. May 31, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207372"], "brand_name": ["NITROFURANTOIN"], "generic_name": ["NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-625"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN", "NITROFURANTOIN MONOHYDRATE"], "rxcui": ["1648755"], "spl_id": ["0e77340b-340d-fe13-e063-6294a90a0301"], "spl_set_id": ["736b2487-e83f-d172-e053-2a91aa0ab0cf"], "package_ndc": ["50268-625-11", "50268-625-15"], "original_packager_product_ndc": ["65162-478"], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L", "E1QI2CQQ1I"]}, "product_type": "Drugs", "event_id": "95919", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0168-2025", "product_description": "Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478.  NDC#: 50268-625-15.", "product_quantity": "1016 50-count cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20241204", "center_classification_date": "20241231", "report_date": "20250108", "code_info": "Lot # 47101; Exp. 02/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0188-2025", "product_description": "Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ", "product_quantity": "42,527 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "a) Lot# DT3023051A, exp. date Apr-25;  b) DT3023025A, exp. date Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Hawthorne", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95994", "recalling_firm": "SHOPPERS- PLAZA", "address_1": "Fouad Panchibyaya 12816", "address_2": "", "postal_code": "90250", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via internet sales", "recall_number": "D-0207-2025", "product_description": "FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7", "product_quantity": "172 180-count bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide", "recall_initiation_date": "20241216", "center_classification_date": "20250122", "report_date": "20250129", "code_info": "Batch # 001, exp. date 09/10/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Flushing", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95980", "recalling_firm": "Buy-Herbal", "address_1": "13661 41st Ave", "address_2": "Box 239", "postal_code": "11355-2464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S Nationwide.", "recall_number": "D-0177-2025", "product_description": "Nhan Sam Tuyet Lien Truy Phong Hoan, Capsules, 30-Count Bottles, Manufactured by Yee Hong Pharmaceuticals, SDN, Penang, Malasia.", "product_quantity": "26 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and Chlorpheniramine", "recall_initiation_date": "20241212", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "All codes, unknown expiration dates all before 05/2030.", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125294"], "brand_name": ["GRANIX"], "generic_name": ["TBO-FILGRASTIM"], "manufacturer_name": ["Cephalon, LLC"], "product_ndc": ["63459-910", "63459-912", "63459-918", "63459-920"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["FILGRASTIM"], "rxcui": ["1433768", "1433771", "1442681", "1442683", "2101456", "2101459", "2101464", "2101465"], "spl_id": ["063f36a7-6f99-40fa-af02-8a5183c51e99"], "spl_set_id": ["df918ec2-0907-443f-a52a-b72866959644"], "package_ndc": ["63459-910-01", "63459-910-12", "63459-910-11", "63459-910-15", "63459-910-18", "63459-910-17", "63459-910-36", "63459-912-01", "63459-912-12", "63459-912-11", "63459-912-15", "63459-912-18", "63459-912-17", "63459-912-36", "63459-918-53", "63459-918-59", "63459-920-53", "63459-920-59"], "is_original_packager": [true], "nui": ["M0024696", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["PVI5M0M1GW"]}, "product_type": "Drugs", "event_id": "96115", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0218-2025", "product_description": "Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, NDC 63459-910-11, Blister NDC 63459-910-12; (b)10 syringes in 1 CARTON, NDC 63459-910-15, Blister NDC 63459-910-12; (c) 1 syringe in 1 CARTON, NDC 63459-910-17 without safety guard and blister, Rx Only, Manufactured by: UAB Teva Baltics, Vilnius, Lithuania. Distributed by Teva Pharmaceuticals USA, Inc. North Wales PA 19454. Product of Israel.", "product_quantity": "34,636 cartons", "reason_for_recall": "Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit", "recall_initiation_date": "20250110", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot #  (a) 135738, (b) 137149, (c) 137148, Exp. date 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Racine", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96324", "recalling_firm": "Johnson, S C and Son, Inc", "address_1": "1525 Howe St", "address_2": "", "postal_code": "53403-2237", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States and Canada", "recall_number": "D-0276-2025", "product_description": "Kids by babyganics SPF 50 mineral sunscreen totally tropical (titanium dioxide 3/5%, zinc oxide 7.25%), packaged in 3 OZ spray bottles, Dist. by KAS Direct LLC, 1525 Howe St. Racine, WI 53403, UPC 813277019923 and UPC 813277019916", "product_quantity": "493,462 units", "reason_for_recall": "Chemical Contamination", "recall_initiation_date": "20250213", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "UPC 813277019916  Lot #: A033 / 5880343A, A054 / 2030633A, A058 / 2050633A, A058 / 2050633B, A058 / 2060633A, A058 / 2070633A, A058 / 2040633A, A059 / 2080633A, Exp. Date Feb-25;  A314 / 4513223A, Exp. Date Nov-25; C054 / 2090774A, C057 / 2100774A, Exp. Date Feb-26; C131 / 3201394A, C131 / 3211394A, C131 / 3211394B, C131 / 3211394C, Exp. Date May-26  UPC 813277019923  Lot #: A060 / 3780693A, A060 / 3780693B, Exp. Date Mar-25; C067 / 2110774A, C067 / 2110774B, C067 / 2110774C, Exp. Date Mar-26; C169 / 7921734A, C169 / 7921734B, Exp. Date Jun-26", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-309-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0181-2025", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-309-02 (carton), NDC #: 49884-309-52 (blisters).", "product_quantity": "22,513 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot #s: 550145201, Exp. 08/31/2026; 550175901, 550176001, 550176201, Exp. 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209713"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-965", "68180-966", "68180-967", "68180-968", "68180-969", "68180-970", "68180-971", "68180-972", "68180-973", "68180-974", "68180-975", "68180-976"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["94052e3d-58b2-4f4b-8223-a47281c1a592"], "spl_set_id": ["18717e58-89fb-4e2f-93b6-d6ac3e988d37"], "package_ndc": ["68180-965-03", "68180-965-02", "68180-965-09", "68180-965-01", "68180-966-03", "68180-966-02", "68180-966-09", "68180-966-01", "68180-967-03", "68180-967-02", "68180-967-09", "68180-967-01", "68180-968-09", "68180-968-02", "68180-968-01", "68180-968-03", "68180-969-01", "68180-969-02", "68180-969-03", "68180-969-09", "68180-970-01", "68180-970-02", "68180-970-03", "68180-970-09", "68180-971-01", "68180-971-02", "68180-971-03", "68180-971-09", "68180-972-01", "68180-972-02", "68180-972-03", "68180-972-09", "68180-973-01", "68180-973-02", "68180-973-03", "68180-973-09", "68180-974-01", "68180-974-02", "68180-974-03", "68180-974-09", "68180-975-03", "68180-975-02", "68180-975-01", "68180-975-09", "68180-976-01", "68180-976-02", "68180-976-03", "68180-976-09"], "is_original_packager": [true], "upc": ["0368180973010", "0368180971016", "0368180972013", "0368180969013", "0368180966012", "0368180970019", "0368180968016", "0368180967019", "0368180965015", "0368180976011", "0368180974017"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95892", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "One US distributor in Ohio.", "recall_number": "D-0167-2025", "product_description": "Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03", "product_quantity": "480 1000-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.", "recall_initiation_date": "20241220", "center_classification_date": "20241230", "report_date": "20250108", "code_info": "Lot# LA01276, Exp Date: 07/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0240-2025", "product_description": "Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-757-01.", "product_quantity": "133,824 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232506, 19232397, 19232415, Exp.: 5/2025; 19233791, Exp.: 8/2025; 19234248, Exp.: 9/2025; 19240909, Exp.: 2/2026; 19242598, Exp.:6/2026; 19243163, 19243122, Exp.: 7/2026; 19243884, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["CURAD ALCOHOL PREP PADS"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-827"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["4139066c-97a1-6d62-e063-6394a90a76e7"], "spl_set_id": ["1ce3872e-2307-4a38-bd7d-7eb2b226cf3c"], "package_ndc": ["53329-827-60", "53329-827-36", "53329-827-30", "53329-827-29", "53329-827-40", "53329-827-09", "53329-827-33", "6122405000"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "96404", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-0289-2025", "product_description": "CURAD Alcohol Prep Pads, Sterile, Medium, 2-Ply, Contents: 5 boxes per Carton, 30 Boxes per Case, Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093, USA, Made in India, www.curad.com, 1-800-633-5463, NDC 53329-827-30.", "product_quantity": "1,639,996 pads", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250217", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "SKU: CUR090737RB, Lot: 61224050002"}, {"status": "Ongoing", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125544"], "brand_name": ["INFLECTRA"], "generic_name": ["INFLIXIMAB-DYYB"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-0809"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["INFLIXIMAB"], "rxcui": ["1790541", "1790546"], "spl_id": ["421960f4-55cd-4bf8-9f00-b980b020e7a7"], "spl_set_id": ["37eaca10-d812-48bc-8b8e-b836bfa9968f"], "package_ndc": ["0069-0809-01"], "is_original_packager": [true], "upc": ["0300690809014"], "nui": ["N0000175610", "N0000175451"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "unii": ["B72HH48FLU"]}, "product_type": "Drugs", "event_id": "96167", "recalling_firm": "McKesson", "address_1": "6555 State Highway 161", "address_2": "", "postal_code": "75039-2402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0213-2025", "product_description": "Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01", "product_quantity": "192 vials", "reason_for_recall": "cGMP Deviations: Product intended for quarantine was inadvertently distributed.", "recall_initiation_date": "20250117", "center_classification_date": "20250130", "report_date": "20250205", "code_info": "Lot# 04647349, Exp Date 5/31/2029", "more_code_info": ""}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020161"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-7074", "0990-7075", "0990-7077"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["88bcbbe4-9ebf-4491-874a-c4c4c7f1f90d"], "spl_set_id": ["eb56a807-ea94-4edb-9811-a04b19568468"], "package_ndc": ["0990-7074-26", "0990-7075-14", "0990-7075-26", "0990-7077-14", "0990-7077-26", "0030990707"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96250", "recalling_firm": "ICU Medical, Inc.", "address_1": "600 N Field Dr", "address_2": "", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0268-2025", "product_description": "POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL, 100 mEq/L flexible container, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7074-26; Bar Code (01)00309907074269", "product_quantity": "unknown", "reason_for_recall": "Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq", "recall_initiation_date": "20250213", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot 1023172, Exp Date: 31 January 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0232-2025", "product_description": "Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.", "product_quantity": "56,208 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233756, Exp.: 8/2025; 19235111, Exp.: 11/2025; 19242167, Exp.: 5/2026; 19242180, Exp.: 5/2026."}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0253-2025", "product_description": "Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784.", "product_quantity": "3465 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s:  a) 24210274, Exp 01/31/2025; 24401700, Exp 04/25/2025;  b) 24251067, Exp 03/25/2025; 24421733, Exp 06/03/2025;  c) 24261384, Exp 03/24/2025; 24370127, Exp 04/28/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0252-2025", "product_description": "Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe, Delivers: 0.5 mL, Iron Supplement Drops, Mfg by: Akron Pharma, Pkg by: Safecor, Columbus, OH 43204.  NDC: a) 71399748005, b) 39328055750, c) 69618007059.", "product_quantity": "1535 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s:  a) 24250093, Exp 03/07/2025; 24321592, Exp 04/04/2025; 24280320, Exp 03/27/2025;  b) 24371268, Exp 04/19/2025;  c) 24400519, Exp 04/07/2025; 24500768, Exp 06/24/2025; 25040972, Exp 07/25/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0157-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04", "product_quantity": "20,734 30-count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot DT6023061B Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0194-2025", "product_description": "Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .", "product_quantity": "6429 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #: KDT0124001, Exp 08/31/2026", "more_code_info": ""}, {"status": "Completed", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA214609"], "brand_name": ["VENLAFAXINE"], "generic_name": ["VENLAFAXINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "product_ndc": ["43598-943", "43598-944"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["808744", "808748"], "spl_id": ["79d34297-6604-4031-a89a-8ec557d078d1"], "spl_set_id": ["9312f4df-63d9-4167-880f-36a816870442"], "package_ndc": ["43598-943-30", "43598-943-90", "43598-944-30", "43598-944-90"], "is_original_packager": [true], "upc": ["0343598943909", "0343598944906", "0343598944302", "0343598943305"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "96128", "recalling_firm": "Appco Pharma LLC", "address_1": "262 Old New Brunswick Rd Unit N", "address_2": "", "postal_code": "08854-3756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA.", "recall_number": "D-0208-2025", "product_description": "Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.", "product_quantity": "1380 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet", "recall_initiation_date": "20250116", "center_classification_date": "20250123", "report_date": "20250129", "code_info": "Lot #: 2402101UR, Exp 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96380", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0271-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-746-05", "product_quantity": "11,125 bottles.", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250228", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot#: 240098C, Expiration: 01/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202097"], "brand_name": ["FENTANYL SYSTEM"], "generic_name": ["FENTANYL"], "manufacturer_name": ["ALVOGEN"], "product_ndc": ["47781-423", "47781-424", "47781-426", "47781-427", "47781-428"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["FENTANYL"], "rxcui": ["197696", "245134", "245135", "245136", "577057"], "spl_id": ["25508d17-4c96-00d3-e063-6294a90a3222"], "spl_set_id": ["242759ef-cb6d-4e3e-9f8d-5e31efa1f289"], "package_ndc": ["47781-423-11", "47781-423-47", "47781-424-11", "47781-424-47", "47781-426-11", "47781-426-47", "47781-427-11", "47781-427-47", "47781-428-11", "47781-428-47"], "is_original_packager": [true], "nui": ["N0000175684", "N0000175690"], "pharm_class_moa": ["Full Opioid Agonists [MoA]"], "pharm_class_epc": ["Opioid Agonist [EPC]"], "unii": ["UF599785JZ"]}, "product_type": "Drugs", "event_id": "96222", "recalling_firm": "Alvogen, Inc", "address_1": "44 Whippany Rd Ste 300", "address_2": "N/A", "postal_code": "07960-4558", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0245-2025", "product_description": "Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.", "product_quantity": "112,128 cartons (5 pouches/carton)", "reason_for_recall": "Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.", "recall_initiation_date": "20250131", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot #: 108319, Exp: 04/30/2027"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA088108"], "brand_name": ["METHADONE HYDROCHLORIDE"], "generic_name": ["METHADONE HYDROCHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0054-0709", "0054-0710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHADONE HYDROCHLORIDE"], "rxcui": ["864706", "864718"], "spl_id": ["b1ede48e-d72f-4dcc-a804-453378c1f165"], "spl_set_id": ["50f14803-78c0-4d19-8b5d-9a9c17582ac1"], "package_ndc": ["0054-0709-25", "0054-0709-20", "0054-0710-25", "0054-0710-20"], "is_original_packager": [true], "upc": ["0300540709259", "0300540710255"], "unii": ["229809935B"]}, "product_type": "Drugs", "event_id": "95999", "recalling_firm": "West-Ward Columbus Inc", "address_1": "1809 Wilson Rd", "address_2": "", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0183-2025", "product_description": "Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20", "product_quantity": "2591 100-count boxes", "reason_for_recall": "Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.", "recall_initiation_date": "20241219", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot # AC2556A; Exp. 03/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078761"], "brand_name": ["MORPHINE SULFATE"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-450", "63304-451", "63304-758", "63304-452", "63304-453"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["891874", "891881", "891888", "891893", "892646"], "spl_id": ["39a0166a-c2ca-47bf-8654-85e0a431b9a0"], "spl_set_id": ["736c9b80-682c-4cda-bf18-61b18de0bd39"], "package_ndc": ["63304-450-03", "63304-450-01", "63304-450-05", "63304-451-03", "63304-451-01", "63304-451-05", "63304-758-03", "63304-758-01", "63304-758-05", "63304-758-50", "63304-452-03", "63304-452-01", "63304-452-05", "63304-453-03", "63304-453-01", "63304-453-05"], "is_original_packager": [true], "upc": ["0363304453010", "0363304758016", "0363304452013", "0363304450019", "0363304451016"], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "96242", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within in the USA.", "recall_number": "D-0249-2025", "product_description": "Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901.  Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512.  NDC 63304-452-01", "product_quantity": "9840 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250206", "center_classification_date": "20250303", "report_date": "20250312", "code_info": "Lot #: AD16615, Exp. Date 07/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212824"], "brand_name": ["MEDROXYPROGESTERONE ACETATE"], "generic_name": ["MEDROXYPROGESTERONE ACETATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-329", "55150-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["MEDROXYPROGESTERONE ACETATE"], "rxcui": ["1000126", "1000153"], "spl_id": ["7f75e36b-db42-43ef-b81f-c7c97948b2f5"], "spl_set_id": ["0655670a-d127-4e08-8a23-ace64b2503b2"], "package_ndc": ["55150-329-01", "55150-329-25", "55150-330-01"], "is_original_packager": [true], "upc": ["0355150330010", "0355150329014"], "unii": ["C2QI4IOI2G"]}, "product_type": "Drugs", "event_id": "96018", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0185-2025", "product_description": "medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01  Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India", "product_quantity": "19872 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20241218", "center_classification_date": "20250106", "report_date": "20250115", "code_info": "Lot No.: 1MP24069, Exp.: 08/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0243-2025", "product_description": "Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-760-01.", "product_quantity": "58,416 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233234, 19233253, Exp.: 7/2025; 19234154, Exp.: 9/2025; 19243185, Exp.: 7/2026; 19243951, 19243974, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0261-2025", "product_description": "Alprostadil   Container Description: Amber color bottle", "product_quantity": "3.0 gm", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HAALC0020922 exp. date AUG-2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Wuxi", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96210", "recalling_firm": "Wuxi Medical lnstrument Factory Co., Ltd.", "address_1": "D, Zhangjing", "address_2": "No. 43 Xixin Road; Xibeizhen Xishan", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0247-2025", "product_description": "ViaMed Alcohol Prep Pads, For External Use Only, 70% Isopropyl Alcohol, Sterile, 100 pieces per Box, 100 boxes per Carton, Sterile, Manufactured by Wuxi Medical Instrument Factory Co., Ltd., Made in China, Manufactured for: Rece International Corp., Miami Lakes, FL, 33014, USA, NDC: 70006-500-01.", "product_quantity": "37,500 Boxes", "reason_for_recall": "Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.", "recall_initiation_date": "20250212", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot #s: 200830, Exp 08/29/2025; 210925, Exp 09/24/2026; 221225, Exp 12/24/2027."}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96380", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0270-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10", "product_quantity": "14,749 bottles.", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250228", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot#: 240225C, Expiration: 01/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212144"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-861", "68462-862", "68462-863", "68462-864", "68462-865"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["440a4208-83cc-4ffa-952c-d9c0745c342a"], "spl_set_id": ["a6065ac5-a111-449b-b51b-8bc2907d1ddb"], "package_ndc": ["68462-861-01", "68462-861-10", "68462-862-01", "68462-862-10", "68462-863-01", "68462-863-10", "68462-864-01", "68462-864-10", "68462-865-01", "68462-865-10"], "is_original_packager": [true], "upc": ["0368462862018", "0368462864012", "0368462863015", "0368462861011"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "95936", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0160-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01", "product_quantity": "", "reason_for_recall": "CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20241211", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot#: 17230133, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209745"], "brand_name": ["SILODOSIN"], "generic_name": ["SILODOSIN"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-777", "42291-778"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SILODOSIN"], "rxcui": ["809477", "826612"], "spl_id": ["0e9abeed-2337-d18a-e063-6394a90a4127"], "spl_set_id": ["ea3bbafb-d32a-d0d3-e053-2a95a90ac387"], "package_ndc": ["42291-777-30", "42291-778-90"], "is_original_packager": [true], "nui": ["N0000000099", "N0000175553"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]"], "unii": ["CUZ39LUY82"]}, "product_type": "Drugs", "event_id": "96247", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0229-2025", "product_description": "Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90", "product_quantity": "1266 bottles", "reason_for_recall": "Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)", "recall_initiation_date": "20250204", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot#: BC20223A, Exp. March 31, 2025."}, {"status": "Ongoing", "city": "Collegeville", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96121", "recalling_firm": "Provepharm Inc.", "address_1": "100 Springhouse Dr Ste 105", "address_2": "N/A", "postal_code": "19426-4709", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0230-2025", "product_description": "Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single unit), Dist. by: Provepharm, Inc., Collegeville, PA 19426", "product_quantity": "24640 vials", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20250121", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot#  24020027, Exp Date: 12/31/2025"}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021269"], "brand_name": ["CARDURA"], "generic_name": ["DOXAZOSIN MESYLATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["58151-078", "58151-079"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXAZOSIN MESYLATE"], "rxcui": ["636360", "636361", "1242404", "1242408"], "spl_id": ["7fe31b0a-4fb2-427f-83e2-d5b957d6738b"], "spl_set_id": ["355bcdce-0481-48ba-8ebd-2009106aaf77"], "package_ndc": ["58151-078-93", "58151-079-93"], "is_original_packager": [true], "upc": ["0358151078936"], "unii": ["86P6PQK0MU"]}, "product_type": "Drugs", "event_id": "96036", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0203-2025", "product_description": "Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93", "product_quantity": "1,215/30 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.", "recall_initiation_date": "20241223", "center_classification_date": "20250116", "termination_date": "20251112", "report_date": "20250122", "code_info": "Lot # 8181625, Exp 12/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96419", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0257-2025", "product_description": "Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50", "product_quantity": "4,190 bottles", "reason_for_recall": "Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.", "recall_initiation_date": "20250210", "center_classification_date": "20250307", "termination_date": "20250814", "report_date": "20250319", "code_info": "Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078203"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6007", "0904-6008", "0904-6009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LORAZEPAM"], "rxcui": ["197900", "197901", "197902"], "spl_id": ["6b6c2fbc-d12d-41d7-b49d-cf374c773cbd"], "spl_set_id": ["62f6eb3b-813d-4890-aca9-799b7fa890df"], "package_ndc": ["0904-6007-60", "0904-6007-61", "0904-6008-60", "0904-6008-61", "0904-6009-60", "0904-6009-61"], "original_packager_product_ndc": ["69315-904", "69315-905", "69315-906"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "96151", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide U.S. and Puerto rico", "recall_number": "D-0227-2025", "product_description": "Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-905 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6008-61.", "product_quantity": "94,349 cartons", "reason_for_recall": "Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.", "recall_initiation_date": "20250121", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot #s: N01419, N01420, N01421, Exp 03/31/2025; N01663, Exp 06/30/2025; N01664, Exp 08/31/2025; N01673, Exp 09/30/2025; N01688, Exp 08/31/2025; N01747, N01748, N01749, Exp 11/30/2025; N01792, Exp 12/31/2025; N01857, Exp 02/28/2026; N01974, Exp 05/31/2026; N02081, Exp 08/31/2026."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0233-2025", "product_description": "Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.", "product_quantity": "175,920 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233792, Exp.: 8/2025; 19233795, Exp.: 8/2025; 19234258, Exp.: 9/2025; 19240912, Exp.: 2/2026; 19241476, 19241477, Exp.: 3/2026; 19242599, Exp.: 6/2026; 19243163, 19243162, Exp.:7/2026;19243884, 19243887, Exp.:9/2026."}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["MEDLINE ALCOHOL PREP"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-811"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["41483c3f-f207-027f-e063-6394a90aea68"], "spl_set_id": ["c9fae7b6-2f4b-490b-9b17-a7297e738069"], "package_ndc": ["53329-811-30", "53329-811-09", "6122404005"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "96404", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-0288-2025", "product_description": "Medline Alcohol Prep Pads, 70% Isopropyl Alcohol, 100 Sterile 2-Ply Pads, Single Use Only, Large, www.medline.com, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, 1-800-MEDLINE, NDC 53329-811-30.", "product_quantity": "6,669,874 pads", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250217", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "SKU: MDS090670, Lot: 61224040057"}, {"status": "Ongoing", "city": "Grand Prairie", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96465", "recalling_firm": "Fruit Of The Earth, Inc.", "address_1": "1430 Avenue R", "address_2": "N/A", "postal_code": "75050-1605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0283-2025", "product_description": "Walgreens Maximum Strength Tinted Acne Treatment Cream 10% Benzoyl Peroxide/Acne Medication, 0.65 oz (18.4g) tube in a carton; Distributed by: Walgreen CO., 200 Wilmot Rd., Deerfield, IL 60015", "product_quantity": "100,970 tubes", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20250311", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 4970743B, 4970743C Exp 3/31/2026, 9722793A, Exp 9/30/2026; 8363513A, Exp 12/3/2026; 2822284A, Exp 8/31/2027; 2143554A, Exp 12/31/2027."}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209718"], "brand_name": ["CLOBAZAM"], "generic_name": ["CLOBAZAM"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOBAZAM"], "rxcui": ["199450"], "spl_id": ["3d5d1f23-c639-3604-e063-6294a90ac606"], "spl_set_id": ["8fce3252-95f8-4428-9922-5ba308e20177"], "package_ndc": ["60687-423-11", "60687-423-21"], "original_packager_product_ndc": ["69238-1305"], "nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "unii": ["2MRO291B4U"]}, "product_type": "Drugs", "event_id": "96017", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0184-2025", "product_description": "Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-21", "product_quantity": "5,178 cartons", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20241213", "center_classification_date": "20250106", "report_date": "20250115", "code_info": "Lot #: 1019594, Exp. Date 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0260-2025", "product_description": "Bimatoprost  NDC# 82187-1001-1  Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.", "product_quantity": "400.0 gm", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HABTC0020123, exp. date Dec-2026 HABTC0050623, exp. date May-2027 HABTC0091023, exp. date Sep-2028", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0197-2025", "product_description": "Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8028-1.", "product_quantity": "7198 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDC0124001A Exp 09/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96307", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0272-2025", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, 855-275-2270, NDC 71285-6092-1.", "product_quantity": "1546 bags", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250220", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot 37-928390, Exp Date, 03MAR2025; Lot 37-928796, Exp Date, 09MAR2025; Lot 37-928839, Exp Date, 10MAR2025", "more_code_info": ""}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["43063-877"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596930"], "spl_id": ["3285a9f3-82fd-8b46-e063-6294a90ab809"], "spl_set_id": ["696a345f-d70c-4ce8-94f7-a8a21f2d20f0"], "package_ndc": ["43063-877-90"], "original_packager_product_ndc": ["57237-018"], "upc": ["0343063877906"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95922", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed within US: FL, MS, WI", "recall_number": "D-0163-2025", "product_description": "DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90", "product_quantity": "70, 90-count bottles", "reason_for_recall": "CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit", "recall_initiation_date": "20241204", "center_classification_date": "20241223", "termination_date": "20250321", "report_date": "20250101", "code_info": "Lot # I24E77, A24E49, Exp Date: 04/30/25;  J23C50, J23C97, L23B39, L23E98, Exp Date: 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0237-2025", "product_description": "Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-271-30.", "product_quantity": "39,168 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers:  19234955, 19234956, Exp.: 11/2025; 19240971, Exp.: 2/2026; 19241864, Exp.: 4/2026."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0242-2025", "product_description": "Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-759-01.", "product_quantity": "53,952 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234630, Exp.: 10/2025; 19240529, Exp.: 1/2026."}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95777", "recalling_firm": "MXBBB", "address_1": "1162 Tio Dink Cir", "address_2": "", "postal_code": "79907-1912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was sold via Amazon Marketplace.", "recall_number": "D-0166-2025", "product_description": "UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323", "product_quantity": "321 bottles", "reason_for_recall": "cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.", "recall_initiation_date": "20241114", "center_classification_date": "20241226", "report_date": "20250101", "code_info": "Lot#: 24183, Exp 07/01/28", "more_code_info": ""}, {"status": "Ongoing", "city": "Benton", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96328", "recalling_firm": "One Source Nutrition, Inc,", "address_1": "19863 Interstate 30 S", "address_2": "N/A", "postal_code": "72015-6966", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0281-2025", "product_description": "Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme Potency.", "product_quantity": "a) 300 individually wrapped capsules b) 20 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.", "recall_initiation_date": "20250220", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "All lots"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0190-2025", "product_description": "Duloxetine DR Capsules USP 60  mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ", "product_quantity": "244,460 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "Lot # a) DT6023053A, DT6023061A, DT6023068A, DT6023074A, exp. date Jan-25;  DT6023078A, DT6023076A, exp. date Feb-25;  DTC24043A, DTC24044A, exp. date Dec-25   b) DT6023002A, DT6023016A, DT6023036A, exp. date Dec-24;  DT6023048A, exp. date Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0193-2025", "product_description": "Acetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8022-01.", "product_quantity": "768 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDT0224002A, Exp 09/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021269"], "brand_name": ["CARDURA"], "generic_name": ["DOXAZOSIN MESYLATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["58151-078", "58151-079"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXAZOSIN MESYLATE"], "rxcui": ["636360", "636361", "1242404", "1242408"], "spl_id": ["7fe31b0a-4fb2-427f-83e2-d5b957d6738b"], "spl_set_id": ["355bcdce-0481-48ba-8ebd-2009106aaf77"], "package_ndc": ["58151-078-93", "58151-079-93"], "is_original_packager": [true], "upc": ["0358151078936"], "unii": ["86P6PQK0MU"]}, "product_type": "Drugs", "event_id": "96036", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0204-2025", "product_description": "Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93", "product_quantity": "6,605/30 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.", "recall_initiation_date": "20241223", "center_classification_date": "20250116", "termination_date": "20251112", "report_date": "20250122", "code_info": "Lot# 8182298, Exp 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0196-2025", "product_description": "Acetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manufactured for:  Akron Pharma Inc., 373 US RT 46 W Building E, Suite 117, Fairfield, NJ 07034, NDC 71399-8022-02", "product_quantity": "1232 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #s: KDT0224001B, Exp 08/31/2026; KDT0224002B, Exp 09/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Thousand Oaks", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103353"], "brand_name": ["NEUPOGEN"], "generic_name": ["FILGRASTIM"], "manufacturer_name": ["Amgen, Inc"], "product_ndc": ["55513-209", "55513-530", "55513-546", "55513-924"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["FILGRASTIM"], "rxcui": ["727535", "727537", "727544", "727545", "1649944", "1649946", "1649963", "1649964"], "spl_id": ["cc41b9c3-f2de-416f-9396-acdc8dac69b9"], "spl_set_id": ["97cc73cc-b5b7-458a-a933-77b00523e193"], "package_ndc": ["55513-530-01", "55513-530-10", "55513-530-20", "55513-546-01", "55513-546-10", "55513-546-20", "55513-924-01", "55513-924-10", "55513-924-91", "55513-924-20", "55513-209-01", "55513-209-10", "55513-209-91", "55513-209-20"], "is_original_packager": [true], "upc": ["0355513530101", "0355513546102"], "nui": ["M0024696", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["PVI5M0M1GW"]}, "product_type": "Drugs", "event_id": "96325", "recalling_firm": "Amgen, Inc.", "address_1": "1 Amgen Center Dr", "address_2": "N/A", "postal_code": "91320-1730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy/San Marino, Netherlands, Poland, Spain/Andorra, Sweden, Finland, Switzerland/Liechtenstein, United Kingdom of Great Britain and Northern Ireland, Ireland, Denmark, Canada, Hong Kong, Philippines, Israel, Malaysia, Saudi Arabia, Gibraltar.", "recall_number": "D-0286-2025", "product_description": "Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box).", "product_quantity": "258,750 Vials", "reason_for_recall": "Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.", "recall_initiation_date": "20250227", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot 1147308, 1154183, Exp.: 2/28/2025; 1156807, 1160222, Exp.: 6/30/2025; 1160223, 1163912, 1167352, Exp.: 2/28/2026; 1171365, 1175057, 1176250, Exp.: 11/30/2026."}]